APAC Advanced Wound Care Market To Reach $3.06 Billion By 2030

Asia Pacific Advanced Wound Care Market Growth & Trends

The Asia Pacific advanced wound care market size is anticipated to reach USD 3.06 billion by 2030 and is projected to grow at a CAGR of 5.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising incidence of chronic wounds is the major factor contributing to the market growth. For instance, in January 2023, MiMedx Group, Inc., a prominent player in placental biologics, secured an exclusive distribution partnership with Gunze Medical Limited, a subsidiary of Gunze Limited, to market EPIFIX exclusively in Japan.

Improvements in healthcare infrastructure and surgical accessibility drive demand for advanced wound care solutions, spurred by increasing surgical procedures and the prevalence of chronic diseases and age-related conditions. According to the United Nations ESCAP (Economic and Social Commission for Asia and the Pacific), by 2023, the Asia Pacific region is expected to have approximately 697 million individuals aged 60 years or older, constituting approximately 60% of the global older population, with one in every seven individuals in the region falling into this age group. Projections indicated that by 2050, one in every four individuals in the region will be aged 60 years or older.

Moreover, the rising prevalence of chronic ailments such as diabetes, cancer, and autoimmune disorders is expected to elevate the occurrence of chronic wounds in the Asia Pacific region. According to the World Health Organization (WHO), within the WHO South-East Asia Region, diabetes affects over 96 million individuals, leading to significant economic burdens on patients, their families, healthcare systems, and national economies due to associated complications such as blindness, kidney failure, heart attacks, strokes, and lower limb amputations.

 Request a free sample copy or view report summary: Asia Pacific Advanced Wound Care Market Report

Asia Pacific Advanced Wound Care Market Report Highlights

• Based on product, the moist segment led the market with the largest revenue share of 55.08% in 2023, owing to the increasing geriatric population in many Asian countries, coupled with rising incidences of chronic diseases such as diabetes. This has led to a higher prevalence of chronic injuries that require advanced wound care solutions. Also, the active segment is expected to grow at the fastest CAGR over the forecast period.

• Based on application, the chronic wounds segment held the market with the largest revenue share of 59.4% in 2023, owing to the technological advancements, encompassing a range of solutions, such as advanced injury dressings, negative pressure wound therapy systems, bioactive wound care products, and topical oxygen therapy devices, among others. On the other hand, the acute wounds segment is expected to grow at the fastest CAGR over the forecast period.

• Based on end use, the hospitals segment led the market with the largest revenue share of 46.9% in 2023, as chronic diseases and aging increase, hospitals face more patients needing advanced wound care, which boosts the demand for related products and treatments. The home healthcare segment is expected to grow at the fastest CAGR over the forecast period.

• China dominated the market with the highest revenue share of 20.77% in 2023, owing to the presence of key players and the rising geriatric population.

Asia Pacific Advanced Wound Care Market Segmentation

Grand View Research has segmented the Asia Pacific advanced wound care market report based on product, application, end-use, and country:

Asia Pacific Advanced Wound Care Product Outlook (Revenue, USD Million, 2018 - 2030)

• Moist

  • Foam Dressings

    • Adhesive

    • Non-adhesive Foam Dressings

  • Superabsorbent Dressings

  • Film Dressings

  • Hydrocolloid Dressings

  • Alginate Dressings

  • Hydrogel Dressings

  • Collagen Dressings

  • Charcoals Dressings

  • Wound Contact Layers

  • Greasy Gauzes

  • Other Advanced Dressings

• Antimicrobial

  • Silver Dressings

  • Non-silver Dressings

    • Honey

    • Iodine

    • Chitosan

    • PHMB

    • Others

• Active

  • Biomaterials

  • Skin-substitute

  • Growth factors

• Wound Cleanser Products

  • Wetting Agents

  • Antiseptic

  • Moisturizers

  • Pulsed Lavage Systems

    • Disposable

    • Reusable

    • Semi Disposable              

  • Others

• Compression Bandages

  • Long-Stretch Elastic Bandages

  • Short-Stretch Bandages

  • Multi-layer Bandages

Asia Pacific Advanced Wound Care Application Outlook (Revenue, USD Million, 2018 - 2030)

• Chronic Wounds

  • Diabetic Foot Ulcers

  • Pressure Ulcers

    • Stage 1

    • Stage 2

    • Stage 3

    • Stage 4

    • Deep Tissue Injury

  • Venous Leg Ulcers

  • Other Chronic Wounds

• Acute Wounds

  • Surgical & Traumatic Wounds

  • Burns

    • 1st Degree Burns

    • 2nd Degree Burns

    • 3rd Degree Burns

Asia Pacific Advanced Wound Care End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Outpatient Facilities

• Home Care

• Others

Asia Pacific Advanced Wound Care Country Outlook (Revenue, USD Million, 2018 - 2030)

• China

• India

• Australia

• Singapore

• Vietnam

• Thailand

• Indonesia

• South Korea

• Hong Kong

• Malaysia 

List of Key Players in the Asia Pacific Advanced Wound Care Market

• Mölnlycke Health Care AB

• 3M

• Smith & Nephew

• Baxter International

• Cardinal Health

• Medline Industries, Inc.

• ConvaTec Inc.

• Johnson & Johnson Services, Inc.

• Integra LifeSciences Corporation

• B. Braun Melsungen AG

• Coloplast Corp.

• Urgo Medical